Research Article
[Retracted] Additional Benefits Conferred by Endoscopic Sclerotherapy to Liver Cirrhosis Patients Receiving Endoscopic Variceal Ligation
Table 2
Comparison of the overall response rate among the three groups.
| | Group | Excellent response (n (%)) | Good response (n (%)) | Nonresponse (n (%)) | Overall response rate (%) |
| | Ligation group (n = 45) | 20 (44.44) | 16 (35.56) | 9 (20.00) | 36 (80.00) | | Sclerotherapy group (n = 45) | 19 (42.22) | 18 (40.00) | 8 (17.78) | 37 (82.22) | | Combined group (n = 45) | 28 (62.22) | 15 (33.33) | 2 (4.44) | 43 (95.56) | | χ2/P (ligation vs. sclerotherapy) | | | | 0.073/0.788 | | χ2/P (ligation vs. combined) | | | | 5.075/0.024 | | χ2/P (sclerotherapy vs. combined) | | | | 4.050/0.044 |
|
|
